Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2017.6.72

Boika A.V.1, Ponomarev V.V.1, Homichenko T.V.2
Sleep disturbance in Parkinson’s disease: the role of immune mechanisms
1Belarusian Medical Academy of Post-Graduate Education, Minsk, Republic of Belarus
2The 5-th City Clinical Hospital, Minsk, Republic of Belarus

Vestnik VGMU. 2017;16(6):72-78.

Abstract.
Introduction. Cytokines and cortisol are involved in the implementation of complex functions of the central nervous system and have an important influence on the development of neurodegenerative diseases and sleep-wake rhythm disturbances.
Objectives. To determine the correlation between the levels of IL-1β, IL-10, as well as cortisol in serum and cerebrospinal fluid (CSF) with the value of sleep disturbances in Parkinson’s disease (PD), assessed by means of scales: Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS).
Material and methods. 31 patients (males (M): females (F) = 0,94: 1; their age (median) was 66 years [58, 72]) of the main group (MG) and 8 persons of the control group (CG, (M: F = 3: 1, their age (median) was 60 years [58, 75])) were studied. The differences between the MG and the CG in age were not statistically significant (p=0,85). The investigation was approved by the ethical committees concerned. The use of diagnostic methods was carried out in accordance with the regulations of Helsinki Declaration of 1975. The collection of biological specimens (blood and CSF) was performed in the first half of the day.The evaluation of sleep disturbances was carried out in the morning after the intake of antiparkinsonian drugs. Nonparametric methods of statistics were used.
Results. A wide prevalence of sleep disorders in people with PD was confirmed. The differences between the MG and the CG were statistically significant (p≤0,05) by the ESS and PSQI scales. In the MG, statistically significant differences between subgroups F and M were obtained only by the PSQI scale (p=0,027). Statistically significant correlations between the value of daytime sleepiness and IL-10 levels in CSF (r=-0,48; p=0,02), and cortisol levels in serum (r=-0,45; p=0,03) were detected for individuals of the MG.
Conclusions. Neuroinflammation is involved in the pathogenesis of sleep disorders in PD. There is the prospect for further research in this direction.
Key words: neuroinflammation, Parkinson’s disease, cytokines, cortisol, sleep disturbance.

References

1. Gjerstad MD, Wentzel-Larsen T, Aarsland D, Larsen JP. Insomnia in Parkinson’s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry. 2007 May; 78(5): 476–479. doi: http://dx.doi.org/10.1136/jnnp.2006.100370
2. Oerlemans WG, de Weerd AW. The prevalence of sleep disorders in patients with Parkinson’s disease. A self-reported, community-based survey. Sleep Med. 2002 Mar;3(2):147-9.
3. Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M, et al. Peripheral cytokines profile in Parkinson’s disease. Brain Behav Immun. 2009 Jan;23(1):55-63. doi: http://dx.doi.org/10.1016/j.bbi.2008.07.003
4. Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nat Rev Neurosci. 2009 Mar;10(3):199-210. doi: http://dx.doi.org/10.1038/nrn2576
5. Bryant PA, Trinder J, Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol. 2004 Jun;4(6):457-67. doi: http://dx.doi.org/10.1038/nri1369
6. Young MR, Matthews JP, Kanabrocki EL, Sothern RB, Roitman-Johnson B, Scheving LE. Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-a, and granulocyte-macrophage colony-stimulating factor in men. Chronobiol Int. 1995 Feb;12(1):19-27.
7. Morris CJ, Aeschbach D, Scheer FA. Circadian system, sleep and endocrinology / C. J. Morris, D. Aeschbach, F. A. Scheer. Mol Cell Endocrinol. 2012 Feb;349(1):91-104. doi: http://dx.doi.org/10.1016/j.mce.2011.09.003
8. Dimitrov S, Benedict C, Heutling D, Westermann J, Born J, Lange T. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood. 2009 May;113(21):5134-43. doi: http://dx.doi.org/10.1182/blood-2008-11-190769
9. Zoccolella S, Savarese M, Lamberti P, Manni R, Racchetti C, Logroscino G. Sleep disorders and the natural history of Parkinson’s disease: the contributionof epidemiological studies. Sleep Med Rev. 2011 Feb;15(1):41-50. doi: http://dx.doi.org/10.1016/j.smrv.2010.02.004
10. Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J. Progressive sleep ‘destructuring’ in Parkinson’s disease. A polysomnographic study in 46 patients. Sleep Med. 2005 Jul;6(4):313-8. doi: http://dx.doi.org/10.1016/j.sleep.2005.03.011
11. Kudo T, Loh DH, Truong D, Wu Y, Colwell CS. Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol. 2011 Nov;232(1):66-75. doi: http://dx.doi.org/10.1016/j.expneurol.2011.08.003
12. Adams KL, Castanon-Cervantes O, Evans JA, Davidson AJ. Environmental circadian disruption elevates the IL-6 response to lipopolysaccharide in blood. J Biol Rhythms. 2013 Aug;28(4):272-7. doi: http://dx.doi.org/10.1177/0748730413494561
13. Yi PL, Tsai CH, Lu MK, Liu HJ, Chen YC, Chang FC. Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism. Sleep. 2007 Apr;30(4):413-25.
14. Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson’s disease: an in vivo 11C-raclopride PET study. Exp Neurol. 2008 Nov;214(1):112-6. doi: http://dx.doi.org/10.1016/j.expneurol.2008.07.021

Information about authors:
Boika A.V. – Candidate of Medical Sciences, doctoral candidate of the Chair of Neurology & Neurosurgery, Belarusian Medical Academy of Post-Graduate Education;
Ponomarev V.V. – Doctor of Medical Sciences, professor, head of the Chair of Neurology & Neurosurgery, Belarusian Medical Academy of Post-Graduate Education;
Homichenko T.V. – head of the neurologic department No. 2, the 5-th City Clinical Hospital.

Correspondence address: Republic of Belarus, 220013, Minsk, 3-3 P. Brovki str., Belarusian Medical Academy of Post-Graduate Education. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Alexander V. Boika.

Поиск по сайту